Supplied as high-purity lyophilized powder, it is used in laboratory and preclinical research models to investigate multi-pathway metabolic signaling, energy homeostasis, and coordinated endocrine receptor activation
Phase 2 results have been published in obesity (Jastreboff and colleagues, N Engl J Med, 2023) and in type 2 diabetes (Rosenstock and colleagues, Lancet, 2023), and the compound has since progressed into the phase 3 TRIUMPH programme
At BODYWELLE, I use individualized treatment planning and careful follow-up to help patients manage side effects with appropriate, currently available weight management options
Explore full compound insights: Related Research Resources Disclaimer The statements made regarding this product have not been evaluated by regulatory authorities
Aid in blood sugar regulation
Retatrutide might work best when combined with a strategy that encourages you to eat better and move more